Spots Global Cancer Trial Database for urinary bladder cancer
Every month we try and update this database with for urinary bladder cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinicoepidimiological Study and Clinical Outcome in Patients With Urinary Bladder Cancer | NCT04525781 | Urinary Bladder... | 18 Years - 70 Years | Assiut University | ||
| Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ | NCT00462488 | Urinary Bladder... Bladder Cancer Bladder Neoplas... Bladder Tumors | Vicinium | 18 Years - | Sesen Bio, Inc. | |
| Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients | NCT06307704 | Prostate Cancer Urinary Bladder... Surgery Positive End Ex... Lung Ultrasound | Lung Ultrasound... Standard Ventil... | 18 Years - 70 Years | Cairo University | |
| Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection | NCT05787938 | Urinary Bladder... | MRI | 40 Years - 100 Years | Assiut University | |
| Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients | NCT06307704 | Prostate Cancer Urinary Bladder... Surgery Positive End Ex... Lung Ultrasound | Lung Ultrasound... Standard Ventil... | 18 Years - 70 Years | Cairo University | |
| Multimodal Spectroscopy to Detect Urothelial Cancer in Urine | NCT04718948 | Urothelial Carc... Urinary Bladder... Urinary Tract C... | Urinary Multimo... Urine Cytology Surgery | 18 Years - | University of Florence | |
| Longitudinal Geriatric Assessment to Optimize Outcomes of Older Patients With Muscle-Invasive Bladder Cancer After Radical Cystectomy | NCT05335707 | Urinary Bladder... | 65 Years - | University of Kansas Medical Center | ||
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. | NCT03335059 | Bladder Cancer Bladder Neoplas... Bladder Tumors Cancer of Bladd... Cancer of the B... Malignant Tumor... Neoplasms, Blad... Urinary Bladder... Carcinoma in Si... Papillary Carci... BCG-Unresponsiv... | Synergo® RITE +... | 18 Years - | Medical Enterprises Ltd. | |
| PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer | NCT01374789 | Urinary Bladder... | GemCis + Panitu... GemCis | 18 Years - | WiSP Wissenschaftlicher Service Pharma GmbH | |
| A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer | NCT02897765 | Urinary Bladder... Bladder Tumors Transitional Ce... Malignant Melan... Melanoma Skin Cancer Carcinoma, Non-... Lung Cancer | NEO-PV-01 Nivolumab Adjuvant | 18 Years - | BioNTech SE | |
| Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | NCT00722553 | Carcinoma, Tran... Bladder Cancer Bladder Neoplas... | Pralatrexate In... Vitamin B12 Folic Acid | 18 Years - | Acrotech Biopharma Inc. | |
| Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients | NCT06307704 | Prostate Cancer Urinary Bladder... Surgery Positive End Ex... Lung Ultrasound | Lung Ultrasound... Standard Ventil... | 18 Years - 70 Years | Cairo University | |
| Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer | NCT00384891 | Urinary Bladder... Urinary Bladder... Urinary Bladder... Malignant Tumor... Urologic Diseas... Urologic Neopla... Neoplasms Neoplasms by Si... | Synergo + MMC Bacillus Calmet... | 18 Years - | Medical Enterprises Europe B.V. | |
| Carboplatin-gemcitabine Versus Cisplatin- Gemcitabine as Neoadjuvant Chemotherapy for Treatment of Muscle Invasive Urinary Bladder Cancer | NCT05822934 | Urinary Bladder... | Carboplatin-Gem... | 18 Years - | Assiut University | |
| Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients | NCT06307704 | Prostate Cancer Urinary Bladder... Surgery Positive End Ex... Lung Ultrasound | Lung Ultrasound... Standard Ventil... | 18 Years - 70 Years | Cairo University | |
| Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma | NCT04812145 | Urinary Bladder... | Chemoradiation | 18 Years - | Assiut University | |
| Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects | NCT04861584 | Urinary Bladder... | Neoadjuvant Tor... | 18 Years - 75 Years | Zhujiang Hospital | |
| Intravesical Gemcitabine in Patients With NMIBC | NCT05644041 | Urinary Bladder... | Gemcitabine | 18 Years - | University of Arizona | |
| Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | NCT02139371 | Breast Cancer Prostate Cancer Urinary Bladder... | Injection of 64... | 18 Years - 80 Years | Rigshospitalet, Denmark | |
| Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | NCT02437539 | Breast Cancer Prostate Cancer Urinary Bladder... | Injection of 68... Positron Emissi... | 18 Years - 80 Years | Rigshospitalet, Denmark | |
| Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder | NCT03529890 | Urinary Bladder... | Nivolumab Radiation thera... Radical cystect... | 18 Years - | Technical University of Munich | |
| PURO Panitumumab in Combination With Gemcitabine/Cisplatin in Advanced Urothelial Cancer | NCT01374789 | Urinary Bladder... | GemCis + Panitu... GemCis | 18 Years - | WiSP Wissenschaftlicher Service Pharma GmbH | |
| Clinicoepidimiological Study and Clinical Outcome in Patients With Urinary Bladder Cancer | NCT04525781 | Urinary Bladder... | 18 Years - 70 Years | Assiut University | ||
| Quantifying Systemic Immunosuppression to Personalize Cancer Therapy | NCT05621837 | Melanoma Breast Cancer Renal Cell Carc... Urinary Bladder... Squamous Cell C... Small Cell Carc... NSCLC | MDSC quantifica... | 18 Years - 90 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Molecular Analysis Of Bladder Cancer | NCT00871754 | Bladder Cancer Bladder Neoplas... | 18 Years - | Lahey Clinic | ||
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | NCT05699135 | Urinary Bladder... Bladder Cancer Bladder Tumors Urothelial Carc... | Avelumab first-... | 18 Years - | Pfizer | |
| Evaluation of NanoDoce® in Participants With Urothelial Carcinoma | NCT03636256 | Bladder Cancer Urothelial Carc... Urinary Bladder... Urinary Bladder... Urogenital Neop... Urologic Neopla... Urologic Cancer Malignant Tumor... Cancer of the B... | NanoDoce (direc... NanoDoce (intra... Institutional S... NanoDoce (intra... | 18 Years - | NanOlogy, LLC | |
| Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | NCT02437539 | Breast Cancer Prostate Cancer Urinary Bladder... | Injection of 68... Positron Emissi... | 18 Years - 80 Years | Rigshospitalet, Denmark | |
| Patterns of Urinary Bladder Cancer in Darfur, Suda | NCT06156787 | Urinary Bladder... | 18 Years - | National Center for Gastroentestinal and Liver Disease | ||
| A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study | NCT03844256 | Urinary Bladder... Invasive Bladde... | nivolumab 480mg nivolumab 3mg/k... nivolumab 1mg/k... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| MAGE-A4ᶜ¹º³²T for Multi-Tumor | NCT03132922 | Urinary Bladder... Melanoma Head and Neck C... Ovarian Cancer Non-Small Cell ... Esophageal Canc... Gastric Cancer Synovial Sarcom... Myxoid Round Ce... Gastroesophagea... | Autologous gene... Autologous gene... | 18 Years - 75 Years | Adaptimmune | |
| A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | NCT05699135 | Urinary Bladder... Bladder Cancer Bladder Tumors Urothelial Carc... | Avelumab first-... | 18 Years - | Pfizer | |
| Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer | NCT05946369 | Urinary Bladder... Urinary Bladder... BCG Trans Urethral ... Non-Muscle Inva... | Neutrophil to l... | - | Ain Shams University | |
| Prehabilitation to Enhance Postoperative Functional Capacity Following Radical Cystectomy | NCT01836978 | Bladder Cancer Entire Ileal Co... Urinary Bladder... | Prehabilitation | 18 Years - 85 Years | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
| A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 | NCT05614739 | Urinary Bladder... Neoplasm Metast... Ureteral Neopla... | LOXO-435 Pembrolizumab | 18 Years - | Eli Lilly and Company | |
| Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder | NCT00722553 | Carcinoma, Tran... Bladder Cancer Bladder Neoplas... | Pralatrexate In... Vitamin B12 Folic Acid | 18 Years - | Acrotech Biopharma Inc. | |
| A Study of LOXO-435 in Participants With Cancer With a Change in a Gene Called FGFR3 | NCT05614739 | Urinary Bladder... Neoplasm Metast... Ureteral Neopla... | LOXO-435 Pembrolizumab | 18 Years - | Eli Lilly and Company | |
| Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma | NCT04004442 | Urothelial Carc... | Avelumab AVB-S6-500 | 18 Years - | University of Oklahoma | |
| Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder | NCT03529890 | Urinary Bladder... | Nivolumab Radiation thera... Radical cystect... | 18 Years - | Technical University of Munich | |
| Clinicoepidimiological Study and Clinical Outcome in Patients With Urinary Bladder Cancer | NCT04525781 | Urinary Bladder... | 18 Years - 70 Years | Assiut University | ||
| Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. | NCT03335059 | Bladder Cancer Bladder Neoplas... Bladder Tumors Cancer of Bladd... Cancer of the B... Malignant Tumor... Neoplasms, Blad... Urinary Bladder... Carcinoma in Si... Papillary Carci... BCG-Unresponsiv... | Synergo® RITE +... | 18 Years - | Medical Enterprises Ltd. | |
| MAGE-A4ᶜ¹º³²T for Multi-Tumor | NCT03132922 | Urinary Bladder... Melanoma Head and Neck C... Ovarian Cancer Non-Small Cell ... Esophageal Canc... Gastric Cancer Synovial Sarcom... Myxoid Round Ce... Gastroesophagea... | Autologous gene... Autologous gene... | 18 Years - 75 Years | Adaptimmune | |
| Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer | NCT05072600 | Bladder Cancer Bladder Neoplas... Bladder Tumors Urinary Bladder... Neoplasms, Blad... | Pembrolizumab | 18 Years - | Peking University First Hospital | |
| Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection | NCT05787938 | Urinary Bladder... | MRI | 40 Years - 100 Years | Assiut University | |
| Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma | NCT04812145 | Urinary Bladder... | Chemoradiation | 18 Years - | Assiut University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
